LegacyXChange (LEGX) 10-Q 5 Aug 15 2016 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Jun. 30, 2015	Aug. 05, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	LegacyXChange, Inc.
Entity Central Index Key	1,423,579
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Document Type	10-Q
Document Period End Date	Jun. 30, 2015
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2,016
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		43,348,238

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2015	Mar. 31, 2015
CURRENT ASSETS:
Cash	$ 1,926	$ 4,362
Prepaid expenses	51,291	$ 28,801
Inventories	570
Total Current Assets	53,787	$ 33,163
TOTAL ASSETS	53,787	33,163
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	128,744	113,747
Accrued officer salary and director fees	4,250	8,050
Derivative liabilities	1,063,040	1,088,085
Total Current Liabilities	1,196,034	1,209,882
Convertible notes payable, net of discount	105,209	70,087
TOTAL LIABILITIES	$ 1,301,243	$ 1,279,969
COMMITMENTS (Note 9)
STOCKHOLDERS' DEFICIT:
Preferred stock ($0.001 par value; 10,000,000 shares authorized; No share issued or outstanding at June 30, 2015 and March 31, 2015)
Common stock, ($0.001 par value; 190,000,000 shares authorized; 38,383,154 and 36,951,165 shares issued and outstanding at June 30, 2015 and March 31, 2015, respectively)	$ 38,383	$ 36,951
Additional paid-in capital	8,396,431	8,332,206
Accumulated deficit	(9,682,270)	(9,615,963)
TOTAL STOCKHOLDERS' DEFICIT	(1,247,456)	(1,246,806)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 53,787	$ 33,163

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2015	Mar. 31, 2015
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	190,000,000	190,000,000
Common stock, shares issued	38,383,154	36,951,165
Common stock, shares outstanding	38,383,154	36,951,165

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Income Statement [Abstract]
REVENUE, NET		$ 723
COST OF REVENUE		1,307
GROSS LOSS		(584)
OPERATING EXPENSES
Compensation and related taxes	$ 33,971	33,703
Professional fees	110,599	74,209
Other selling, general and administrative	15,278	14,489
TOTAL OPERATING EXPENSES	159,848	122,401
LOSS FROM OPERATIONS	(159,848)	$ (122,985)
OTHER INCOME (EXPENSE)
Interest expense	(46,504)
Initial derivative expense	(119,455)
Gain from change in fair value of derivative liabilities	$ 259,500
Loss on settlement of loans		$ (5,510)
TOTAL OTHER INCOME (EXPENSE)	$ 93,541	(5,510)
NET LOSS	$ (66,307)	$ (128,495)
NET LOSS PER COMMON SHARE
Basic and diluted	$ 0	$ 0
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING:
Basic and diluted	37,582,645	33,757,488

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Deficit - 3 months ended Jun. 30, 2015 - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance at Mar. 31, 2015	$ (1,246,806)		$ 36,951	$ 8,332,206	$ (9,615,963)
Beginning balance, shares at Mar. 31, 2015			36,951,165
Stock issued for services, value	38,990		$ 705	38,285
Stock issued for services, shares			705,000
Stock issued for accounts payable - related party, value	26,667		$ 727	$ 25,940
Stock issued for accounts payable - related party, shares			726,989
Net loss	(66,307)				$ (66,307)
Ending balance at Jun. 30, 2015	$ (1,247,456)		$ 38,383	$ 8,396,431	$ (9,682,270)
Ending balance, shares at Jun. 30, 2015			38,383,154

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (66,307)	$ (128,495)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expenses	$ 14,045	47,983
Loss on settlement of loans		$ 5,510
Amortization of debt discount	$ 35,122
Gain from change in fair value of derivative liabilities	(259,500)
Initial fair value of derivative liabilities	119,455
Changes in operating assets and liabilities:
Prepaid expenses	$ 2,455	$ (3,039)
Security deposit		$ 636
Inventories	$ (570)
Accounts payable and accrued liabilities	$ 41,664	$ 2,203
Deferred revenue		(327)
Accrued officer salary and director fees	$ (3,800)	2,700
Due to shareholders		(5,171)
Due to officer		(60)
Net cash used in operating activities	$ (117,436)	$ (78,060)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds received from convertible notes	$ 115,000
Proceeds received from sale of stock		$ 70,895
Net cash provided by financing activities	$ 115,000	70,895
NET DECREASE IN CASH AND CASH EQUIVALENTS	(2,436)	(7,165)
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	4,362	9,345
CASH AND CASH EQUIVALENTS - END OF PERIOD	$ 1,926	$ 2,180
Cash paid for:
Interest
Income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issued for future services	$ 32,990	$ 5,510
Stock issued for accrued liabilities	$ 26,667
Stock issued for loans' principal		$ 20,000
Stock issued for accrued interest		2,000
Stock issued for common stock subscription advances		$ 113,525
Initial debt discount recorded on convertible notes	$ 115,000

Organization and Nature of Oper

Organization and Nature of Operations	3 Months Ended
	Jun. 30, 2015
Organization and Nature of Operations [Abstract]
ORGANIZATION AND NATURE OF OPERATIONS	NOTE 1 – ORGANIZATION AND NATURE OF OPERATIONS LegacyXChange, Inc. (formerly True 2 Beauty, Inc.) (the “Company”) was originally incorporated as Burrow Mining, Inc., a Nevada corporation, on December 11, 2006. In February 2010, the Company shifted its focus to the beauty industry and later amended its Articles of Incorporation and changed its name to True 2 Beauty, Inc., to better reflect its new business focus. On July 10, 2012, the Company formed a new wholly owned subsidiary True2Bid, Inc. (“True2Bid”) which was incorporated in the state of Nevada. This subsidiary’s name was changed to LegacyXChange, Inc. (“LegacyXChange”) in December 2014. The Company continued to sell existing inventory of beauty products through May 2013 when the final inventory was sold. LegacyXChange operates an online e-commerce platform focused on delivering users a wide array of sports and entertainment related products that can be won in an action packed environment of a live auction. On July 2, 2015, pursuant to a Certificate of Dissolution filing with the Nevada Secretary of State, we dissolved LegacyXChange, Inc. (formerly True2Bid, Inc.) to allow for the change in name of our parent company, True 2 Beauty, Inc., to LegacyXChange, Inc. On June 24, 2015, our Board of Directors approved of a name change from True 2 Beauty, Inc. to LegacyXChange, Inc. (the “Name Change”) and on June 29, 2015 shareholders holding 51.8% of our issued and outstanding shares approved and adopted the Name Change. The State of Nevada approved the Certificate of Amendment affecting the Name Change on July 6, 2015 to be effective as of July 2, 2015.

Basis of Presentation, Going Co

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies	3 Months Ended
	Jun. 30, 2015
Organization and Nature of Operations [Abstract]
BASIS OF PRESENTATION, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – BASIS OF PRESENTATION, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation Management acknowledges its responsibility for the preparation of the accompanying unaudited consolidated financial statements which reflect all adjustments, consisting of normal recurring adjustments, considered necessary in its opinion for a fair statement of its consolidated financial position and the consolidated results of its operations for the periods presented. The accompanying unaudited consolidated financial statements include the financial statement of its wholly-owned subsidiary, LegacyXChange, Inc. All intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited consolidated financial statements for True 2 Beauty Inc. and its subsidiary have been prepared in accordance with accounting principles generally accepted in the United States of America (the “U.S. GAAP”) for interim financial information and with the instructions Article 8-03 of Regulation S-X. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. These unaudited consolidated financial statements should be read in conjunction with the summary of significant accounting policies and notes to the consolidated financial statements for the years ended March 31, 2015 and 2014 included in the Company’s Form 10-K. Going concern These unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, the Company had a net loss of $66,307 and $128,495 for the three months ended June 30, 2015 and 2014, respectively, and net cash used in operations of $117,436 and $78,060 for the three months ended June 30, 2015 and 2014, respectively, and an accumulated deficit, a stockholders’ deficit and a working capital deficit of $9,682,270, $1,247,456 and $1,142,247, respectively, at June 30, 2015, did not generate any revenue for the three months ended June 30, 2015 and had a gross loss for the three months ended June 30, 2014. These matters raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital, implement its business plan, and generate significant revenues. The unaudited consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. The Company plans on raising capital through the sale of equity or debt instruments to implement its business plan. There is no assurance these plans will be realized. Use of estimates The preparation of the unaudited consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates during the three months ended June 30, 2015 and 2014 include the valuation of deferred tax assets, valuation of derivative liabilities and the valuation of stock-based compensation and fees. Fair value of financial instruments and fair value measurements The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: ● Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. ● Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. ● Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The carrying amounts reported in the unaudited consolidated balance sheets for cash, inventories, accounts payable and accrued liabilities, accrued officer salary and director fees, approximate their fair market value based on the short-term maturity of these instruments. Certain financial instruments, such as certain accrued liabilities, embody obligations that require (or permit at the Company’s discretion) settlement by issuance of a variable number of the Company’s common shares that have a value equal to a fixed monetary amount. The number of shares required to be issued to settle that unconditional obligation is variable, because that number of common shares will be determined by the fair value of the Company’s common shares on the date of settlement or over a stated period of time, such as the average over the last 30 days before settlement, or the beginning of the quarter. Pursuant to ASC 480-10-25-14(a), the financial instruments are classified as a liability at the fixed monetary amount with a charge to expense to increase the obligation to the fixed monetary amount. Upon issuance of the shares to settle the obligation, equity is increased by the amount of the liability and no gain or loss is recognized for the difference between the settlement date or average market price and the ending market price. The following table reflects changes for the three months ended June 30, 2015 for all financial assets and liabilities categorized as Level 3: Derivative Fixed Monetary Obligation Balance as of March 31, 2015 $ 1,088,085 $ 6,667 Initial fair value of derivative liabilities attributable to conversion feature 234,455 - Decrease in fair value of fixed monetary obligation - (6,667 ) Gain from change in the fair value of derivative liabilities (259,500 ) - Balance as of June 30, 2015 $ 1,063,040 $ - ASC 825-10 “ Financial Instruments , Cash and cash equivalents Cash and cash equivalents consist of cash and short-term highly liquid investments purchased with original maturities of three months or less. There were no cash equivalents at June 30, 2015 and March 31, 2015. Inventories and cost of revenue Inventories are stated at the lower of cost or market value. Cost is determined using the cost to acquire inventory and is valued using the first-in, first-out method. Any inventory adjustments are based upon management’s review of inventories on hand compared to estimated future usage and sales. Inventories of finished goods totaled $570 and $0 at June 30, 2015 and March 31, 2015, respectively. Revenue recognition The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the purchase price is fixed or determinable and collectability is reasonably assured. The Company’s specific revenue recognition policies are as follows: ● Product sales from the sale of beauty products by the parent entity (which ceased in May 2013) and sales of products through the subsidiary’s auction site are recognized when the product is shipped to the customer and title is transferred. ● To participate in the Company’s auction program, consumers are required to purchase bid packages directly from the Company. Proceeds from the sales of bid packages are recorded as deferred revenue until recognizable as discussed below. In connection with the sale of bid packages, the Company utilized the User-based Revenue Model (“UBRM”). The UBRM is based on the presumption that the period of delivery for the bid package is the estimated average user life which was estimated by the Company to be 60 days. Consequently, revenue from the sale of bid packages is recognized ratably over the estimated user life of 60 days. Stock-based compensat ion Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. Pursuant to ASC 505-50, for share-based payments to consultants and other third-parties, compensation expense is determined at the “measurement date.” The expense is recognized over the service period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date. Income taxes Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the asset or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company follows the provisions of FASB ASC 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a “more-likely-than-not” threshold. As of June 30, 2015 and March 31, 2015, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying unaudited consolidated financial statements. Shipping costs Shipping costs are included in other selling, general and administrative expense and totaled $2 and $95 for the three months ended June 30, 2015 and 2014, respectively. Advertising Advertising is expensed as incurred and is included in other selling, general and administrative expense. The Company did not incur any advertising expense for the three months ended June 30, 2015 and 2014. Research and development Expenditures for research and product development costs are expensed as incurred. The Company did not incur any research and development expense during the three months ended June 30, 2015 and 2014. Basic and diluted earnings per share Pursuant to ASC 260-10-45, basic earnings (loss) per common share is computed by dividing income (loss) allocable to common shareholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. Diluted income (loss) per share reflects the potential dilution that could occur if securities were exercised or converted into common stock or other contracts to issue common stock resulting in the issuance of common stock that would then share in the Company’s income (loss) subject to anti-dilution limitations. Potentially dilutive common shares consist of common stock issuable for stock warrants (using the treasury stock method). For the three months ended June 30, 2015 and 2014, all potentially dilutive securities are excluded from the computation of diluted weighted average number of shares of common stock outstanding as they would have had an anti-dilutive impact. The Company’s aggregate common stock equivalents at June 30, 2015 and 2014 included the following: June 30, June 30, Stock warrants 3,348,315 1,046,440 Total 3,348,315 1,046,440 Related parties Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions are recorded at fair value of the goods or services exchanged. Recent accounting pronouncements Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its consolidated financial condition, results of operations, cash flows or disclosures.

Prepaid Expenses

Prepaid Expenses	3 Months Ended
	Jun. 30, 2015
Prepaid Expenses [Abstract]
PREPAID EXPENSES	NOTE 3 – PREPAID EXPENSES At June 30, 2015 and March 31, 2015, prepaid expenses consisted of the following: June 30, March 31, 2015 Prepaid professional service fees $ 49,891 $ 28,801 Prepaid other expense 1,400 - $ 51,291 $ 28,801

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	3 Months Ended
	Jun. 30, 2015
Accounts Payable And Accrued Liabilities [Abstract]
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES At June 30, 2015 and March 31, 2015, accounts payable and accrued liabilities consisted of the following: June 30, March 31, 2015 Accrued interest $ 29,075 $ 17,693 Accrued professional fees 66,508 67,364 Accrued payroll taxes 31,161 28,690 Other 2,000 - $ 128,744 $ 113,747

Accrued Officer Salary and Dire

Accrued Officer Salary and Director Fees	3 Months Ended
	Jun. 30, 2015
Accrued Officer Salary and Director Fees [Abstract]
Accrued officer salary and director fees	NOTE 5 – ACCRUED OFFICER SALARY AND DIRECTOR FEES In connection with the employment of a board of director member, the Company has agreed to compensate him as follows: an initial payment of $1,500 and quarterly payments of $1,500 during the term which he serves as a director of the Company. At June 30, 2015 and March 31, 2015, the amount due to this director was $3,250 and $4,750, respectively, and was included in accrued officer salary and director fees in the accompanying consolidated balance sheets. At June 30, 2015 and March 31, 2015, the accrued and unpaid CEO’s salary was $1,000 and $3,300, respectively, and was included in accrued officer salary and director fees in the accompanying consolidated balance sheets. At June 30, 2015 and March 31, 2015, accrued officer salary and director fees consisted of the following: June 30, March 31, 2015 Accrued director's salary $ 3,250 $ 4,750 Accrued officer’s salary 1,000 3,300 $ 4,250 $ 8,050

Related Party Transactions

Related Party Transactions	3 Months Ended
	Jun. 30, 2015
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 6 – RELATED PARTY TRANSACTIONS Effective November 1, 2014, the Company entered into a service agreement with CFO Oncall Inc., a company majority owned by the Company’s chief financial officer. In accordance with the service agreement, the service fee is $5,000 per month which is payable as $3,000 in cash payable in advance on the 1 st

Convertible Notes Payable

Convertible Notes Payable	3 Months Ended
	Jun. 30, 2015
Convertible Notes Payable [Abstract]
CONVERTIBLE NOTES PAYABLE	NOTE 7 – CONVERTIBLE NOTES PAYABLE Fiscal 2015 Convertible Notes In October and November 2014, the Company and 7 subject to adjustment for issuances of common stock at a purchase price of less than the then-effective conversion price investors (the “Investors”) entered into convertible promissory note agreements, providing the issuance of a 10% convertible promissory notes (the “Convertible Notes”) with an aggregate principal amount of $400,000. The Convertible Notes are due and payable on the third anniversary of the date of issuance through October 2017. The Investors are entitled, at their option, at any time after the issuance of these Convertible Notes, to convert all or any lesser portion of the outstanding principal amount and accrued but unpaid interest into the Company’s common stock at a conversion price for each share of common stock equal to $0.02. The conversion price of the Convertible Notes shall be. In the event a registration statement is not filed by either the Company within 60 days following the completion of this Offering, or the full amount of Conversion Shares are not included in the first registration statement filed by either entity, or if such registration statement including the Conversion Shares is not declared effective within 180 days following the completion of the Offering, the Convertible Notes shall then be convertible at the option of the Holder into shares of the common stock, par value $.001 per share, of the Company at a conversion price equal to the lesser of $0.02 per share or a 25% discount to the average closing bid price of the Parent Company’s stock for the five days immediately prior to the day upon which the Company receives a written conversion notice from the Holder for any portion of the Notes. The Penalty Conversion shall remain in effect until such time as a registration statement from the Company, including the Conversion Shares is declared effective by the SEC. In connection with the issuance of these Convertible Notes above, the Company determined that the terms of the Convertible Notes include a down-round provision under which the conversion price and exercise price could be affected by future equity offerings undertaken by the Company or contain terms that are not fixed monetary amounts at inception. Accordingly, under the provisions of FASB ASC Topic No. 815-40, “Derivatives and Hedging – Contracts in an Entity’s Own Stock”, the embedded conversion option contained in the convertible instruments were accounted for as derivative liabilities at the date of issuance and shall be adjusted to fair value through earnings at each reporting date. The fair value of the embedded conversion option derivatives was determined using the Binomial Option Pricing Model. On the initial measurement date, the fair value of the embedded conversion option derivative of $419,000 was recorded as a derivative liability and was allocated as a debt discount up to the proceeds of the notes $383,125 with the remainder $35,875 charged to current period operations as initial derivative expense. Any gains and losses recorded from changes in the fair value of the liability for derivative contract was recorded as a component of other income/(expense) in the accompanying consolidated statements of operations. During the three months ended June 30, 2015, the fair value of the derivative liabilities were estimated using the Binomial option-pricing model with the following assumptions: Dividend rate 0 Term (in years) 2.29 years Volatility 168.29 % Risk-free interest rate 1.01 % At June 30, 2015 and March 31, 2015, the Company valued the embedded conversion option derivative liabilities resulting in a gain from change in fair value of derivative liabilities of $225,995 for the three months ended June 30, 2015. For the three months ended June 30, 2015, amortization of debt discounts related to these convertible notes amounted to $31,927, which has been included in interest expense on the accompanying consolidated statements of operations. At June 30, 2015 and March 31, 2015, fiscal 2015 convertible promissory notes consisted of the following: June 30, March 31, 2015 Principal amount $ 400,000 $ 400,000 Less: unamortized debt discount (297,986 ) (329,913 ) Convertible notes payable, net $ 102,014 $ 70,087 Fiscal 2016 Convertible Notes On May 19, 2015 and June 1, 2015 and June 23, 2015, the Company and 5 investors (the “Investors”) entered into convertible promissory note agreements, providing the issuance of a 10% convertible promissory notes (the “Fiscal 2016 Convertible Notes”) with an aggregate principal amount of $115,000. The Fiscal 2016 Convertible Notes are due and payable on the third anniversary of the date of May 19, 2018 and June 1, 2018 and June 23, 2018. The Investors are entitled, at their option, at any time after the issuance of these Fiscal 2016 Convertible Notes, to convert all or any lesser portion of the outstanding principal amount and accrued but unpaid interest into the Company’s common stock at a conversion price for each share of common stock equal to $0.05. The conversion price of the Fiscal 2016 Convertible Notes shall be subject to adjustment for issuances of common stock at a purchase price of less than the then-effective conversion price. In connection with the issuance of these Fiscal 2016 Convertible Notes, the Company issued five-year common stock purchase warrants (“Warrants”) exercisable at $0.07 per share. These investors received 20 Warrants for each dollar invested in the Fiscal 2016 Convertible Notes. The exercise price of the Warrant shall be subject to adjustment for issuance of common stock at a consideration per share of less than the then-effective exercise price. In connection with the issuance of these Fiscal 2016 Convertible Notes, the Company determined that the terms of the Fiscal 2016 Convertible Notes and the 2,300,000 warrants include down-round provisions under which the conversion price and exercise price could be affected by future equity offerings undertaken by the Company or contain terms that are not fixed monetary amounts at inception. Accordingly, under the provisions of FASB ASC Topic No. 815-40, “Derivatives and Hedging – Contracts in an Entity’s Own Stock”, the embedded conversion option contained in the convertible instruments and the warrants were accounted for as a derivative liabilities at the date of issuance and shall be adjusted to fair value through earnings at each reporting date. The fair value of the embedded conversion option derivatives and warrants derivatives was determined using the Binomial Option Pricing Model. On the initial measurement date, the fair value of the embedded conversion option derivatives and warrants derivatives of $234,455 was recorded as a derivative liability and was allocated as a debt discount up to the proceeds of the notes $115,000 with the remainder $119,455 charged to current period operations as initial derivative expense. Any gains and losses recorded from changes in the fair value of the liability for derivative contract will be recorded as a component of other income/(expense) in the consolidated statements of operations. During the three months ended June 30, 2015, the fair value of the derivative liabilities were estimated using the Binomial option-pricing model with the following assumptions: Dividend rate 0 Term (in years) 2.91 to 5.00 years Volatility 176.29% to 261.24 % Risk-free interest rate 0.99% to 1.71 % At June 30, 2015 and on the initial measurements of the derivative liabilities, the Company valued the embedded conversion option derivative liabilities and warrants derivative resulting in a gain from change in fair value of derivative liabilities of $33,505 for the three months ended June 30, 2015. For the three months ended June 30, 2015, amortization of debt discounts related to these convertible notes amounted to $3,195, which has been included in interest expense on the accompanying consolidated statements of operations. At June 30, 2015 and March 31, 2015, fiscal 2016 convertible promissory notes consisted of the following: June 30, March 31, Principal amount $ 115,000 $ - Less: unamortized debt discount (111,805 ) - Convertible notes payable, net $ 3,195 $ - At June 30, 2015 and March 31, 2015, the total convertible promissory notes mentioned above consisted of the following: June 30, March 31, Principal amount $ 515,000 $ 400,000 Less: unamortized debt discount (409,791 ) (329,913 ) Convertible notes payable, net $ 105,209 $ 70,087

Stockholders' Deficit

Stockholders' Deficit	3 Months Ended
	Jun. 30, 2015
Stockholders' Deficit [Abstract]
STOCKHOLDERS' DEFICIT	NOTE 8 – STOCKHOLDERS’ DEFICIT Authorized shares The Company is authorized to issue 10,000,000 shares of its $0.001 par value preferred stock. As of June 30, 2015 and March 31, 2015, no shares were issued and outstanding. The Company is authorized to issue 190,000,000 shares of its $0.001 par value common stock. As of June 30, 2015 and March 31, 2015, 38,383,154 and 36,951,165 shares of common stock were issued and outstanding, respectively. Common stock issued for services On April 27, 2015, the Company issued 100,000 shares of common stock to an attorney for services rendered. The shares were valued at the fair market value of $0.06 per share based on the closing bid price on the grant date. The Company recorded stock-based legal fees of $6,000 for the three months ended June 30, 2015. On May 1, 2015, the Company issued 180,000 shares of common stock to an attorney for services to be rendered. The shares were valued at the fair market value of $0.0549 per share based on the closing bid price on the grant date. The Company recorded stock-based legal fees of $1,647 for the three months ended June 30, 2015 and had a remaining prepaid expense of $8,235 at June 30, 2015, which will be amortized over the remaining service period. On May 1, 2015, the Company issued 175,000 vested shares of common stock to an attorney for services to be rendered. The shares were valued at the fair market value of $0.0549 per share on the grant date which is the measurement date based on the closing bid price on the grant date. The Company recorded stock-based legal fees of $1,600 for the three months ended June 30, 2015 and had a remaining prepaid expense of $8,008 at June 30, 2015, which will be amortized over the remaining service period. On June 1, 2015, the Company issued 726,989 shares of common stock to a company controlled by the Company’s chief financial officer for compensation and to settle accrued liabilities of $26,667 pursuant to the related service agreement (See Note 6). The shares were valued at $26,667 based on 60% of the closing bid price of the Company’s common stock on the last trading day of the previous quarter as defined in the service agreement. No gain or loss was recognized on this settlement. On June 1, 2015, the Company issued 250,000 vested shares of common stock to a consultant for marketing services to be rendered. The shares were valued at the fair market value of $0.054 per share on the grant date which is the measurement date based on the closing bid price on the grant date. The Company recorded stock-based marketing service fees of $1,125 for the three months ended June 30, 2015 and had a remaining prepaid expense of $12,375 at June 30, 2015, which will be amortized over the remaining service period. Warrants The Company issued warrants with the sale of common stock during the three months ended June 30, 2015. These warrants have an exercise price of $0.07 per share and expire in 5 years from issuance dates. Warrant activities for the three months ended June 30, 2015 were as follows: Number of Warrants Weighted Average Exercise Price Balance at March 31, 2015 1,048,315 $ 0.40 Issued 2,300,000 0.07 Exercised/forfeited/expired - - Balance at June 30, 2015 3,348,315 $ 0.17 Warrant exercisable at June 30, 2015 3,348,315 $ 0.17 There was no intrinsic value of the warrants at June 30, 2015. The following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at June 30, 2015: Warrants Outstanding Warrants Exercisable Range of Number Range of Weighted Number Weighted $ 0.40 125,000 2.2 $ 0.40 125,000 $ 0.40 0.40 256,250 2.3 0.40 256,250 0.40 0.40 12,500 2.4 0.40 12,500 0.40 0.40 46,105 2.5 0.40 46,105 0.40 0.40 231,876 2.6 0.40 231,876 0.40 0.40 46,877 2.7 0.40 46,877 0.40 0.40 14,063 2.8 0.40 14,063 0.40 0.40 938 2.9 0.40 938 0.40 0.40 39,412 3.8 0.40 39,412 0.40 0.40 273,419 3.9 0.40 273,419 0.40 0.40 1,875 4.0 0.40 1,875 0.40 0.07 2,200,000 4.9 0.07 2,200,000 0.07 0.07 100,000 5.0 0.07 100,000 0.07 $ 0.07 – 0.40 3,348,315 2.2 – 5.0 $ 0.17 3,348,315 $ 0.17

Concentrations and Commitments

Concentrations and Commitments	3 Months Ended
	Jun. 30, 2015
Concentrations and Commitments [Abstract]
CONCENTRATIONS AND COMMITMENTS	NOTE 9 CONCENTRATIONS AND COMMITMENTS Concentrations Customers No customer accounted for 10% or more of the Company’s revenue during the three months ended June 30, 2015 and 2014. Suppliers No supplier accounted for 10% or more of the Company’s purchase during the three months ended June 30, 2015 and 2014. Commitments Service contracts In September 2014, the Company signed an eight-month agreement with Applied DNA to work together, in good faith, on a business partnership focused on using Applied DNA Sciences’ unique SigNature© DNA taggant platform, digitalDNA © software platform and other products as required for DNA marking, tracking and authentication of sports collectibles and sports memorabilia uniquely and authentically identified to an athlete (“Goods”) and offered either within a True2Bid online auction exchange environment or through other means of sale. The agreement requires a cash payment of $35,000, of which $10,000 has been paid and the balance of $25,000 was scheduled to be paid in two payments of $12,500 each on February 1, 2015 and June 1, 2015. However, there has been no development pursuant to the three phases as defined in the agreement and, accordingly, the Company believes an obligation does not exist and does not intend to pay these installments until the milestones are reached. This agreement expired in May 2015. On October 29, 2014, the Company entered into a service agreement with CFO Oncall, effective on November 1, 2014. In accordance to the service agreement, the service fee is $5,000 per month which is payable as follows: $3,000 in cash payable in advance of the 1 st On May 1, 2015, the Company entered into a one-year legal service agreement with an attorney who has agreed to provide corporate and securities related legal services to the Company. The agreement expires on April 30, 2016. In accordance to this legal service agreement, the Company pays (a) a flat cash fee of $1,000 per month; and (b) an annual stock fee of 175,000 shares of the Company’s common stock. The Company issued the 175,000 shares of common stock in June 2015 (See Note 8 – Common stock issued for service). The accrued service fees related to the service agreement at June 30, 2015 was $1,000 which was included in accounts payable and accrued liabilities. On May 1, 2015, the Company entered into a one-year consulting agreement with an attorney who has agreed to provide consulting services to the Company. The agreement expires on April 30, 2016. In accordance to this consulting agreement, the Company pays this consultant (a) $6,000 in equal monthly installments; and (b) 180,000 shares of the Company’s common stock. The Company issued the 180,000 shares of common stock in June 2015 (See Note 8 – Common stock issued for services). The accrued service fees related to the service agreement at June 30, 2015 was $1,000 which was included in accounts payable and accrued liabilities. On June 1, 2015, the Company entered into a one-year consulting agreement with a consultant who has agreed to provide consulting services to the Company. The agreement expires on May 31, 2016. In accordance to this consulting agreement, the Company pays the consultant (a) Per Tier 1 athlete/celebrity: (i) 2,500 shares of the Company’s common stock; (ii) 4% of the advertising revenue generated from items offered for sale on the site related to the athlete/celebrity, which were not sold directly by the athlete/celebrity; (iii) 1% of the net item sales of any original merchandise sold by the athlete/celebrity; (b) For all other tiers, including collectible specialists, corporations: (i) 1,500 shares of the Company’s common stock; (ii) 3% of the advertising revenue generated from items offered for sale on the site related to the athlete/celebrity, which were not sold directly by the athlete/celebrity; (iii) 1% of the net item sales of any original merchandise sold by the athlete/celebrity or entity; (c) 250,000 shares of the Company’s common stock upon signing, plus $3,500 per month for the following services: (i) advisory services related to professional sports franchises; (ii) introduction to sports related industry leaders; (iii) assistance in athlete management; (iv) assistance in athlete promotions. For (a) and (b), the percentage of net sales and percentage of advertising revenue will be paid to the consultant as long as the athlete/celebrity/other remains a vendor for the Company, otherwise the consultant earns no commission or fees. The consultant will be paid any commission on the 10 th

Subsequent Events

Subsequent Events	3 Months Ended
	Jun. 30, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 – SUBSEQUENT EVENTS On December 17, 2014, pursuant to a name change filing with the Nevada Secretary of State, the Company changed the name of its subsidiary, True 2 Bid, Inc., to LegacyXChange, Inc. On July 2, 2015, pursuant to a Certificate of Dissolution filing with the Nevada Secretary of State, the Company dissolved LegacyXChange, Inc. (formerly True2Bid, Inc.) to allow for the change in name of its parent company, True 2 Beauty, Inc., to LegacyXChange, Inc. On June 24, 2015, the Company’s Board of Directors approved of a name change from True 2 Beauty, Inc. to LegacyXChange, Inc. (the “Name Change”) and on June 29, 2015 shareholders holding 51.8% of our issued and outstanding shares approved and adopted the Name Change. The State of Nevada approved the Certificate of Amendment affecting the Name Change on July 6, 2015 to be effective as of July 2, 2015. In connection with the Name Change the Company will: (a) file an Issuer Form with FINRA; (b) have its Transfer Agent file a Transfer Agent Form with FINRA; and (c) file for a new stock symbol with FINRA. On July 9, 2015, $27,510 principal amount of the Company’s Fiscal 2015 Convertible Notes and $10,792 accrued interest was converted into 1,915,084 shares of the Company’s common stock. On July 22, 2015, $36,000 principal amount of the Company’s Fiscal 2015 Convertible Notes was converted into 1,800,000 shares of the Company’s common stock. On July 27, 2015, $25,000 principal amount of the Company’s Fiscal 2015 Convertible Notes was converted into 1,250,000 shares of the Company’s common stock.

Basis of Presentation, Going 17

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Jun. 30, 2015
Organization and Nature of Operations [Abstract]
Basis of presentation	Basis of presentation Management acknowledges its responsibility for the preparation of the accompanying unaudited consolidated financial statements which reflect all adjustments, consisting of normal recurring adjustments, considered necessary in its opinion for a fair statement of its consolidated financial position and the consolidated results of its operations for the periods presented. The accompanying unaudited consolidated financial statements include the financial statement of its wholly-owned subsidiary, LegacyXChange, Inc. All intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited consolidated financial statements for True 2 Beauty Inc. and its subsidiary have been prepared in accordance with accounting principles generally accepted in the United States of America (the “U.S. GAAP”) for interim financial information and with the instructions Article 8-03 of Regulation S-X. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. These unaudited consolidated financial statements should be read in conjunction with the summary of significant accounting policies and notes to the consolidated financial statements for the years ended March 31, 2015 and 2014 included in the Company’s Form 10-K.
Going concern	Going concern These unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, the Company had a net loss of $66,307 and $128,495 for the three months ended June 30, 2015 and 2014, respectively, and net cash used in operations of $117,436 and $78,060 for the three months ended June 30, 2015 and 2014, respectively, and an accumulated deficit, a stockholders’ deficit and a working capital deficit of $9,682,270, $1,247,456 and $1,142,247, respectively, at June 30, 2015, did not generate any revenue for the three months ended June 30, 2015 and had a gross loss for the three months ended June 30, 2014. These matters raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital, implement its business plan, and generate significant revenues. The unaudited consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. The Company plans on raising capital through the sale of equity or debt instruments to implement its business plan. There is no assurance these plans will be realized.
Use of estimates	Use of estimates The preparation of the unaudited consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates during the three months ended June 30, 2015 and 2014 include the valuation of deferred tax assets, valuation of derivative liabilities and the valuation of stock-based compensation and fees.
Fair value of financial instruments and fair value measurements	Fair value of financial instruments and fair value measurements The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: ● Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. ● Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. ● Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The carrying amounts reported in the unaudited consolidated balance sheets for cash, inventories, accounts payable and accrued liabilities, accrued officer salary and director fees, approximate their fair market value based on the short-term maturity of these instruments. Certain financial instruments, such as certain accrued liabilities, embody obligations that require (or permit at the Company’s discretion) settlement by issuance of a variable number of the Company’s common shares that have a value equal to a fixed monetary amount. The number of shares required to be issued to settle that unconditional obligation is variable, because that number of common shares will be determined by the fair value of the Company’s common shares on the date of settlement or over a stated period of time, such as the average over the last 30 days before settlement, or the beginning of the quarter. Pursuant to ASC 480-10-25-14(a), the financial instruments are classified as a liability at the fixed monetary amount with a charge to expense to increase the obligation to the fixed monetary amount. Upon issuance of the shares to settle the obligation, equity is increased by the amount of the liability and no gain or loss is recognized for the difference between the settlement date or average market price and the ending market price. The following table reflects changes for the three months ended June 30, 2015 for all financial assets and liabilities categorized as Level 3: Derivative Fixed Monetary Obligation Balance as of March 31, 2015 $ 1,088,085 $ 6,667 Initial fair value of derivative liabilities attributable to conversion feature 234,455 - Decrease in fair value of fixed monetary obligation - (6,667 ) Gain from change in the fair value of derivative liabilities (259,500 ) - Balance as of June 30, 2015 $ 1,063,040 $ - ASC 825-10 “ Financial Instruments ,
Cash and cash equivalents	Cash and cash equivalents Cash and cash equivalents consist of cash and short-term highly liquid investments purchased with original maturities of three months or less. There were no cash equivalents at June 30, 2015 and March 31, 2015.
Inventories and cost of revenue	Inventories and cost of revenue Inventories are stated at the lower of cost or market value. Cost is determined using the cost to acquire inventory and is valued using the first-in, first-out method. Any inventory adjustments are based upon management’s review of inventories on hand compared to estimated future usage and sales. Inventories of finished goods totaled $570 and $0 at June 30, 2015 and March 31, 2015, respectively.
Revenue recognition	Revenue recognition The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the purchase price is fixed or determinable and collectability is reasonably assured. The Company’s specific revenue recognition policies are as follows: ● Product sales from the sale of beauty products by the parent entity (which ceased in May 2013) and sales of products through the subsidiary’s auction site are recognized when the product is shipped to the customer and title is transferred. ● To participate in the Company’s auction program, consumers are required to purchase bid packages directly from the Company. Proceeds from the sales of bid packages are recorded as deferred revenue until recognizable as discussed below. In connection with the sale of bid packages, the Company utilized the User-based Revenue Model (“UBRM”). The UBRM is based on the presumption that the period of delivery for the bid package is the estimated average user life which was estimated by the Company to be 60 days. Consequently, revenue from the sale of bid packages is recognized ratably over the estimated user life of 60 days.
Stock-based compensation	Stock-based compensat ion Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. Pursuant to ASC 505-50, for share-based payments to consultants and other third-parties, compensation expense is determined at the “measurement date.” The expense is recognized over the service period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date.
Income taxes	Income taxes Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the asset or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company follows the provisions of FASB ASC 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a “more-likely-than-not” threshold. As of June 30, 2015 and March 31, 2015, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying unaudited consolidated financial statements.
Shipping costs	Shipping costs Shipping costs are included in other selling, general and administrative expense and totaled $2 and $95 for the three months ended June 30, 2015 and 2014, respectively.
Advertising	Advertising Advertising is expensed as incurred and is included in other selling, general and administrative expense. The Company did not incur any advertising expense for the three months ended June 30, 2015 and 2014.
Research and development	Research and development Expenditures for research and product development costs are expensed as incurred. The Company did not incur any research and development expense during the three months ended June 30, 2015 and 2014.
Basic and diluted earnings per share	Basic and diluted earnings per share Pursuant to ASC 260-10-45, basic earnings (loss) per common share is computed by dividing income (loss) allocable to common shareholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. Diluted income (loss) per share reflects the potential dilution that could occur if securities were exercised or converted into common stock or other contracts to issue common stock resulting in the issuance of common stock that would then share in the Company’s income (loss) subject to anti-dilution limitations. Potentially dilutive common shares consist of common stock issuable for stock warrants (using the treasury stock method). For the three months ended June 30, 2015 and 2014, all potentially dilutive securities are excluded from the computation of diluted weighted average number of shares of common stock outstanding as they would have had an anti-dilutive impact. The Company’s aggregate common stock equivalents at June 30, 2015 and 2014 included the following: June 30, June 30, Stock warrants 3,348,315 1,046,440 Total 3,348,315 1,046,440
Related parties	Related parties Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions are recorded at fair value of the goods or services exchanged.
Recent accounting pronouncements	Recent accounting pronouncements Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its consolidated financial condition, results of operations, cash flows or disclosures.

Basis of Presentation, Going 18

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Jun. 30, 2015
Organization and Nature of Operations [Abstract]
Schedule of financial assets and liabilities categorized as Level 3	Derivative Fixed Monetary Obligation Balance as of March 31, 2015 $ 1,088,085 $ 6,667 Initial fair value of derivative liabilities attributable to conversion feature 234,455 - Decrease in fair value of fixed monetary obligation - (6,667 ) Gain from change in the fair value of derivative liabilities (259,500 ) - Balance as of June 30, 2015 $ 1,063,040 $ -
Schedule of aggregate common stock equivalents	June 30, June 30, Stock warrants 3,348,315 1,046,440 Total 3,348,315 1,046,440

Prepaid Expenses (Tables)

Prepaid Expenses (Tables)	3 Months Ended
	Jun. 30, 2015
Prepaid Expenses [Abstract]
Schedule of prepaid expenses	June 30, March 31, 2015 Prepaid professional service fees $ 49,891 $ 28,801 Prepaid other expense 1,400 - $ 51,291 $ 28,801

Accounts Payable and Accrued 20

Accounts Payable and Accrued Liabilities (Tables)	3 Months Ended
	Jun. 30, 2015
Accounts Payable And Accrued Liabilities [Abstract]
Schedule of accounts payable and accrued liabilities	June 30, March 31, 2015 Accrued interest $ 29,075 $ 17,693 Accrued professional fees 66,508 67,364 Accrued payroll taxes 31,161 28,690 Other 2,000 - $ 128,744 $ 113,747

Accrued Officer Salary and Di21

Accrued Officer Salary and Director Fees (Tables)	3 Months Ended
	Jun. 30, 2015
Accrued Officer Salary and Director Fees [Abstract]
Schedule of accrued officer salary and director fees	June 30, March 31, 2015 Accrued director's salary $ 3,250 $ 4,750 Accrued officer’s salary 1,000 3,300 $ 4,250 $ 8,050

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	3 Months Ended
	Jun. 30, 2015
Short-term Debt [Line Items]
Schedule of convertible promissory notes	June 30, March 31, Principal amount $ 515,000 $ 400,000 Less: unamortized debt discount (409,791 ) (329,913 ) Convertible notes payable, net $ 105,209 $ 70,087
Fiscal 2015 Convertible Notes [Member]
Short-term Debt [Line Items]
Schedule of fair value of the derivative liabilities	Dividend rate 0 Term (in years) 2.29 years Volatility 168.29 % Risk-free interest rate 1.01 %
Schedule of convertible promissory notes	June 30, March 31, 2015 Principal amount $ 400,000 $ 400,000 Less: unamortized debt discount (297,986 ) (329,913 ) Convertible notes payable, net $ 102,014 $ 70,087
Fiscal 2016 Convertible Notes [Member]
Short-term Debt [Line Items]
Schedule of fair value of the derivative liabilities	Dividend rate 0 Term (in years) 2.91 to 5.00 years Volatility 176.29% to 261.24 % Risk-free interest rate 0.99% to 1.71 %
Schedule of convertible promissory notes	June 30, March 31, Principal amount $ 115,000 $ - Less: unamortized debt discount (111,805 ) - Convertible notes payable, net $ 3,195 $ -

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)	3 Months Ended
	Jun. 30, 2015
Stockholders' Deficit [Abstract]
Summary of warrant activities	Number of Warrants Weighted Average Exercise Price Balance at March 31, 2015 1,048,315 $ 0.40 Issued 2,300,000 0.07 Exercised/forfeited/expired - - Balance at June 30, 2015 3,348,315 $ 0.17 Warrant exercisable at June 30, 2015 3,348,315 $ 0.17
Summary of warrants outstanding	Warrants Outstanding Warrants Exercisable Range of Number Range of Weighted Number Weighted $ 0.40 125,000 2.2 $ 0.40 125,000 $ 0.40 0.40 256,250 2.3 0.40 256,250 0.40 0.40 12,500 2.4 0.40 12,500 0.40 0.40 46,105 2.5 0.40 46,105 0.40 0.40 231,876 2.6 0.40 231,876 0.40 0.40 46,877 2.7 0.40 46,877 0.40 0.40 14,063 2.8 0.40 14,063 0.40 0.40 938 2.9 0.40 938 0.40 0.40 39,412 3.8 0.40 39,412 0.40 0.40 273,419 3.9 0.40 273,419 0.40 0.40 1,875 4.0 0.40 1,875 0.40 0.07 2,200,000 4.9 0.07 2,200,000 0.07 0.07 100,000 5.0 0.07 100,000 0.07 $ 0.07 – 0.40 3,348,315 2.2 – 5.0 $ 0.17 3,348,315 $ 0.17

Basis of Presentation, Going 24

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Details)	3 Months Ended
	Jun. 30, 2015USD ($)
Liabilities:
Balance as of March 31, 2015	$ 1,088,085
Initial fair value of derivative liabilities attributable to conversion feature	234,455
Decrease in fair value of fixed monetary obligation	(6,667)
Gain from change in the fair value of derivative liabilities	(259,500)
Balance as of June 30, 2015	1,063,040
Balance as of March 31, 2015	$ 6,667
Balance as of June 30, 2015

Basis of Presentation, Going 25

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Details 1) - shares	3 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total stock warrants	3,348,315	1,046,440
Stock warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total stock warrants	3,348,315	1,046,440

Basis of Presentation, Going 26

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Mar. 31, 2015
Basis of Presentation Going Concern and Summary of Significant Accounting Policies (Textual)
Net loss	$ (66,307)	$ (128,495)
Net cash used in operating activities	(117,436)	(78,060)
Accumulated deficit	(9,682,270)		$ (9,615,963)
Stockholders deficit	(1,247,456)		$ (1,246,806)
Working capital deficit	1,142,247
Inventories	570
Shipping costs	$ 2	$ 95
Advertising expenses
Research and development expense

Prepaid Expenses (Details)

Prepaid Expenses (Details) - USD ($)	Jun. 30, 2015	Mar. 31, 2015
Prepaid Expenses [Abstract]
Prepaid professional service fees	$ 49,891	$ 28,801
Prepaid other expense	1,400
Total prepaid expenses	$ 51,291	$ 28,801

Accounts Payable and Accrued 28

Accounts Payable and Accrued Liabilities (Details) - USD ($)	Jun. 30, 2015	Mar. 31, 2015
Accounts Payable And Accrued Liabilities [Abstract]
Accrued interest	$ 29,075	$ 17,693
Accrued professional fees	66,508	67,364
Accrued payroll taxes	31,161	$ 28,690
Other	2,000
Accounts payable and accrued liabilities, Total	$ 128,744	$ 113,747

Accrued Officer Salary and Di29

Accrued Officer Salary and Director Fees (Details) - USD ($)	Jun. 30, 2015	Mar. 31, 2015
Related Party Transaction [Line Items]
Accrued officer salary and director fees	$ 4,250	$ 8,050
Director [Member]
Related Party Transaction [Line Items]
Accrued officer salary and director fees	3,250	4,750
Officer [Member]
Related Party Transaction [Line Items]
Accrued officer salary and director fees	$ 1,000	$ 3,300

Accrued Officer Salary and Di30

Accrued Officer Salary and Director Fees (Detail Textual) - USD ($)	3 Months Ended
	Jun. 30, 2015	Mar. 31, 2015
Accrued Officer Salary and Director Fees (Textual)
Initial Payment	$ 1,500
Quarterly Payments	1,500
Accrued Salaries	4,250	$ 8,050
Director [Member]
Accrued Officer Salary and Director Fees (Textual)
Accrued Salaries	3,250	4,750
Officer [Member]
Accrued Officer Salary and Director Fees (Textual)
Accrued Salaries	$ 1,000	$ 3,300

Related Party Transactions (Det

Related Party Transactions (Details) - Chief Financial Officer [Member] - USD ($)	Nov. 01, 2014	Oct. 29, 2014	Jun. 30, 2015
Related Party Transactions (Textual)
Cash paid in advance	$ 3,000
Amount paid in cash or common stock	$ 2,000
Servicing Fees		$ 5,000
Stock issued for accounts payable - related party, shares			726,989
Accounts payable and accrued liabilities.			$ 9,000

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - 3 months ended Jun. 30, 2015 - Fiscal 2016 Convertible Notes [Member]	Total
Short-term Debt [Line Items]
Dividend rate	0.00%
Term (in years)	2 years 3 months 15 days
Volatility	168.29%
Risk-free interest rate	1.01%
Maximum [Member]
Short-term Debt [Line Items]
Term (in years)	5 years
Volatility	261.24%
Risk-free interest rate	1.71%
Minimum [Member]
Short-term Debt [Line Items]
Term (in years)	2 years 10 months 28 days
Volatility	176.29%
Risk-free interest rate	0.99%

Convertible Notes Payable (De33

Convertible Notes Payable (Details 1) - USD ($)	Jun. 30, 2015	Mar. 31, 2015
Short-term Debt [Line Items]
Principal amount	$ 515,000	$ 400,000
Less: unamortized debt discount	(409,791)	(329,913)
Convertible notes payable, net	105,209	70,087
Fiscal 2015 Convertible Notes [Member]
Short-term Debt [Line Items]
Principal amount	400,000	400,000
Less: unamortized debt discount	(297,986)	(329,913)
Convertible notes payable, net	102,014	$ 70,087
Fiscal 2016 Convertible Notes [Member]
Short-term Debt [Line Items]
Principal amount	115,000
Less: unamortized debt discount	(111,805)
Convertible notes payable, net	$ 3,195

Convertible Notes Payable (De34

Convertible Notes Payable (Detail Textual)	3 Months Ended
	Jun. 30, 2015USD ($)Investors$ / sharesshares	Jun. 30, 2014USD ($)	Mar. 31, 2015USD ($)
Short-term Debt [Line Items]
Principal amount of debt	$ 515,000		$ 400,000
Debt Instrument, discount	409,791		329,913
Initial derivative expense	$ 119,455
Warrants exercise price | $ / shares	$ 0.07
Fair value of derivative liabilities	$ (259,500)
Amortization of debt discount	$ 35,122
warrant issued | shares	2,300,000
Fiscal 2015 Convertible Notes
Short-term Debt [Line Items]
Principal amount of debt	$ 400,000
Convertible note interest rate	10.00%
Convertible notes date of issuance	Oct. 31, 2017
Conversion share price | $ / shares	$ 0.02
Convertible note, description	In the event a registration statement is not filed by either the Company within 60 days following the completion of this Offering, or the full amount of Conversion Shares are not included in the first registration statement filed by either entity, or if such registration statement including the Conversion Shares is not declared effective within 180 days following the completion of the Offering, the Convertible Notes shall then be convertible at the option of the Holder into shares of the common stock, par value $.001 per share, of the Company at a conversion price equal to the lesser of $0.02 per share or a 25% discount to the average closing bid price of the Parent Company's stock for the five days immediately prior to the day upon which the Company receives a written conversion notice from the Holder for any portion of the Notes.
Initial fair value of derivative liabilities attributable to conversion feature	$ 419,000
Debt Instrument, discount	383,125
Initial derivative expense	$ 35,875
Number of Investors | Investors	7
Derivative Liability	$ 225,995
Convertible notes amounted			$ 31,927
Fiscal 2016 Convertible Notes
Short-term Debt [Line Items]
Principal amount of debt	$ 115,000
Convertible note interest rate	10.00%
Conversion share price | $ / shares	$ 0.05
Number of Investors | Investors	5
Initial derivative expense	$ 119,455
Derivative Liability	$ 234,455
Warrants exercise price | $ / shares	$ 0.07
Number of convertion warrant | shares	2,300,000
Proceeds of issuance debt	$ 115,000
Fair value of derivative liabilities	33,505
Amortization of debt discount	$ 3,195

Stockholders' Deficit (Details)

Stockholders' Deficit (Details) - 3 months ended Jun. 30, 2015 - $ / shares	Total
Stockholders' Deficit [Abstract]
Beginning balance	1,048,315
warrant issued	2,300,000
Ending balance	3,348,315
Exercised/forfeited/expired
Warrant exercisable at March 31, 2015	3,348,315
Weighted average exercise price, Beginning balance	$ 0.40
Weighted average exercise price, Issued	$ 0.07
Weighted average exercise price, Exercised/ forfeited/ expired
Weighted average exercise price, Ending balance	$ 0.17
Weighted average exercise price, Exercisable	$ 0.17

Stockholders' Deficit (Details

Stockholders' Deficit (Details 1) - Jun. 30, 2015 - Warrant [Member] - $ / shares	Total
Warrants Outstanding And Exercisable [Abstract]
Warrants Outstanding, Number Outstanding at June 30, 2015	3,348,315
Warrants Outstanding, Weighted Average Exercise Price	$ 0.17
Warrants Exercisable, Number Exercisable at June 30, 2014	3,348,315
Warrants Exercisable, Weighted Average Exercise Price	$ 0.17
Maximum [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.40
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	5 years
Minimum [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.07
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 2 months 12 days
0.40 (Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.40
Warrants Outstanding, Number Outstanding at June 30, 2015	125,000
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 2 months 12 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.40
Warrants Exercisable, Number Exercisable at June 30, 2014	125,000
Warrants Exercisable, Weighted Average Exercise Price	$ 0.40
0.40 One(Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.40
Warrants Outstanding, Number Outstanding at June 30, 2015	256,250
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 3 months 18 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.40
Warrants Exercisable, Number Exercisable at June 30, 2014	256,250
Warrants Exercisable, Weighted Average Exercise Price	$ 0.40
0.40 Two(Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.40
Warrants Outstanding, Number Outstanding at June 30, 2015	12,500
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 4 months 24 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.40
Warrants Exercisable, Number Exercisable at June 30, 2014	12,500
Warrants Exercisable, Weighted Average Exercise Price	$ 0.40
0.40 Three(Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.40
Warrants Outstanding, Number Outstanding at June 30, 2015	46,105
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 6 months
Warrants Outstanding, Weighted Average Exercise Price	$ 0.40
Warrants Exercisable, Number Exercisable at June 30, 2014	46,105
Warrants Exercisable, Weighted Average Exercise Price	$ 0.40
0.40 Four(Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.40
Warrants Outstanding, Number Outstanding at June 30, 2015	231,876
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 7 months 6 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.40
Warrants Exercisable, Number Exercisable at June 30, 2014	231,876
Warrants Exercisable, Weighted Average Exercise Price	$ 0.40
0.40 Five(Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.40
Warrants Outstanding, Number Outstanding at June 30, 2015	46,877
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 8 months 12 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.40
Warrants Exercisable, Number Exercisable at June 30, 2014	46,877
Warrants Exercisable, Weighted Average Exercise Price	$ 0.40
0.40 Six(Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.40
Warrants Outstanding, Number Outstanding at June 30, 2015	14,063
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 9 months 18 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.40
Warrants Exercisable, Number Exercisable at June 30, 2014	14,063
Warrants Exercisable, Weighted Average Exercise Price	$ 0.40
0.40 Seven (Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.40
Warrants Outstanding, Number Outstanding at June 30, 2015	938
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 10 months 24 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.40
Warrants Exercisable, Number Exercisable at June 30, 2014	938
Warrants Exercisable, Weighted Average Exercise Price	$ 0.40
0.40 Eight (Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.40
Warrants Outstanding, Number Outstanding at June 30, 2015	39,412
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	3 years 9 months 18 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.40
Warrants Exercisable, Number Exercisable at June 30, 2014	39,412
Warrants Exercisable, Weighted Average Exercise Price	$ 0.40
0.40 Nine (Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.40
Warrants Outstanding, Number Outstanding at June 30, 2015	273,419
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	3 years 10 months 24 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.40
Warrants Exercisable, Number Exercisable at June 30, 2014	273,419
Warrants Exercisable, Weighted Average Exercise Price	$ 0.40
0.40 Ten [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.40
Warrants Outstanding, Number Outstanding at June 30, 2015	1,875
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	4 years
Warrants Outstanding, Weighted Average Exercise Price	$ 0.40
Warrants Exercisable, Number Exercisable at June 30, 2014	1,875
Warrants Exercisable, Weighted Average Exercise Price	$ 0.40
0.07 Eleven
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.70
Warrants Outstanding, Number Outstanding at June 30, 2015	2,200,000
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	4 years 10 months 24 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.07
Warrants Exercisable, Number Exercisable at June 30, 2014	2,200,000
Warrants Exercisable, Weighted Average Exercise Price	$ 0.07
0.07 Twelve
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.70
Warrants Outstanding, Number Outstanding at June 30, 2015	100,000
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	5 years
Warrants Outstanding, Weighted Average Exercise Price	$ 0.07
Warrants Exercisable, Number Exercisable at June 30, 2014	100,000
Warrants Exercisable, Weighted Average Exercise Price	$ 0.07

Stockholders' Deficit (Detail37

Stockholders' Deficit (Details Textual) - USD ($)	Jun. 01, 2015	May. 01, 2015	Apr. 27, 2015	Jun. 30, 2015	Jun. 30, 2014	Mar. 31, 2015
Stockholders' Deficit (Textual)
Preferred stock, shares authorized				10,000,000		10,000,000
Preferred stock, par value				$ 0.001		$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, shares authorized				190,000,000		190,000,000
Common stock, par value				$ 0.001		$ 0.001
Stock issued for accounts payable - related party, value				$ 26,667
Common stock, shares issued				38,383,154		36,951,165
Common stock, shares outstanding				38,383,154		36,951,165
Term of warrants				5 years
Warrants exercise price				$ 0.07
Common Stock [Member]
Stockholders' Deficit (Textual)
Stock issued for accounts payable - related party, value				$ 727
Common stock issued for services				705,000
Stock issued for accounts payable - related party, shares				726,989
Common Stock [Member] | Attorney [Member]
Stockholders' Deficit (Textual)
Common stock issued for services			100,000
legal fees				$ 6,000
Fair value of shares issued			$ 0.06
Common Stock [Member] | Attorney One [Member]
Stockholders' Deficit (Textual)
Common stock issued for services		180,000
legal fees				1,647
Fair value of shares issued		$ 0.0549
Prepaid expense remaining amount				8,235
Common Stock [Member] | Law Firm [Member]
Stockholders' Deficit (Textual)
Common stock issued for services		175,000
legal fees		$ 1,600
Fair value of shares issued		$ 0.0549
Prepaid expense remaining amount				8,008
Common Stock [Member] | Accounting Firm [Member]
Stockholders' Deficit (Textual)
Common stock issued for services	250,000
Fair value of shares issued	$ 0.054
Prepaid expense remaining amount				12,375
Issuance of common stock, Value				$ 1,125

Concentrations and Commitments

Concentrations and Commitments (Details) - USD ($)	Jun. 01, 2015	May. 01, 2015	Oct. 29, 2014	Jun. 30, 2015	Jun. 30, 2014	Mar. 31, 2015	Feb. 01, 2015	Sep. 30, 2014
Concentrations and Commitments (Textual)
Common stock, shares issued				38,383,154		36,951,165
Common stock, par value				$ 0.001		$ 0.001
Stock-based compensation				$ 14,045	$ 47,983
Installments of cash paid								$ 10,000
June 1, 2015
Concentrations and Commitments (Textual)
Common stock, shares issued	250,000
Commitments, Description	(a) Per Tier 1 athlete/celebrity: (i) 2,500 shares of the Company's common stock; (ii) 4% of the advertising revenue generated from items offered for sale on the site related to the athlete/celebrity, which were not sold directly by the athlete/celebrity; (iii) 1% of the net item sales of any original merchandise sold by the athlete/celebrity; (b) For all other tiers, including collectible specialists, corporations: (i) 1,500 shares of the Company's common stock; (ii) 3% of the advertising revenue generated from items offered for sale on the site related to the athlete/celebrity, which were not sold directly by the athlete/celebrity; (iii) 1% of the net item sales of any original merchandise sold by the athlete/celebrity or entity; (c) 250,000 shares of the Company's common stock upon signing, plus $3,500 per month for the following services: (i) advisory services related to professional sports franchises; (ii) introduction to sports related industry leaders; (iii) assistance in athlete management; (iv) assistance in athlete promotions. For (a) and (b), the percentage of net sales and percentage of advertising revenue will be paid to the consultant as long as the athlete/celebrity/other remains a vendor for the Company, otherwise the consultant earns no commission or fees. The consultant will be paid any commission on the 10th of each month for revenue generated in the preceding month, and the first of every month for the $3,500 monthly payment.
Installments of cash paid	$ 3,500
Agreement expired	The agreement expires on May 31, 2016.
May 1, 2015
Concentrations and Commitments (Textual)
Common stock, shares issued		180,000
Commitments, Description		(a) $6,000 to be paid in equal monthly installments; and (b) 180,000 shares of the Company's common stock.
Installments of cash paid		$ 6,000
Agreement expired		The agreement expires on April 30, 2016.
Accounts payable and accrued liabilities.		$ 1,000
September 2,014
Concentrations and Commitments (Textual)
Cash payment								35,000
Installments of cash paid	$ 12,500						$ 12,500	$ 25,000
Frederick M. Lehrer [Member]
Concentrations and Commitments (Textual)
Common stock, shares issued		175,000
Commitments, Description		(a) a flat cash fee of $1,000 per month; and (b) an annual stock fee of 175,000 shares of the Company's common stock. The Company issued the 175,000 shares of common stock in June 2015
Installments of cash paid		$ 1,000
Agreement expired		The agreement expires on April 30, 2016.
Accounts payable and accrued liabilities.				1,000
CFO Oncall Inc [Member]
Concentrations and Commitments (Textual)
Cash payment			$ 3,000
Service fees			$ 5,000
Percentage of quoted market prices			40.00%
Installments of cash paid			$ 2,000
Stock settled debt			2,000
Premium payment amount			$ 1,333
Accumulated premium included in accounts payable				0		$ 6,667
Accounts payable and accrued liabilities.				$ 9,000

Subsequent Events (DetailsTextu

Subsequent Events (DetailsTextual) - USD ($)	Jul. 27, 2015	Jul. 22, 2015	Jul. 09, 2015	Jun. 30, 2015	Jun. 29, 2015	Mar. 31, 2015
Subsequent Events (Textual)
Shareholders holdings percentage					51.80%
Principal amount of debt				$ 515,000		$ 400,000
Subsequent Event [Member]
Subsequent Events (Textual)
Principal amount of debt	$ 25,000	$ 36,000	$ 27,510
Debt instrument, Accrued interest			$ 10,792
Debt conversion, Converted into common stock, Shares	1,250,000	1,800,000	1,915,084